Bruker Corporation to Participate in the Jefferies Virtual London Healthcare Conference
November 16 2020 - 7:30AM
Business Wire
Bruker Corporation (Nasdaq: BRKR) announced today it will
participate in the Jefferies Virtual London Healthcare Conference.
Gerald Herman, Chief Financial Officer, will participate in an
analyst moderated question and answer session on behalf of the
company on Wednesday, November 18, 2020 at 2:05 PM Greenwich Mean
Time (9:05 AM Eastern Standard Time).
A live audio webcast of the question and answer session will be
available on the Investor Relations section of the Company's
website at https://ir.bruker.com . A replay will be posted in the
“Events & Presentations” section of the Bruker Corporation
Investor Relations website after the event and will be available
for 30 days following the event.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high-performance scientific instruments and
high-value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular research, in applied and pharma applications, in
microscopy and nanoanalysis, and in industrial applications, as
well as in cell biology, preclinical imaging, clinical phenomics
and proteomics research and clinical microbiology. For more
information, please visit: www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201116005430/en/
Miroslava Minkova Director, Investor Relations & Corporate
Development Bruker Corporation T: +1 (978) 663 – 3660, ext. 1479 E:
Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Apr 2023 to Apr 2024